发明名称 STABLE IgG4 ANTIBODIES
摘要 PROBLEM TO BE SOLVED: To provide stabilized IgG4 antibodies reduced in the ability to subject to Fab arm exchange, a method for producing the antibodies, and an application of the antibodies as a medicament.SOLUTION: A stabilized IgG4 antibody for use as a medicament, comprising a heavy chain and a light chain, where the heavy chain comprises a human IgG4 constant region having a substitution of the Arg residue at position 409, the Phe residue at position 405 or the Lys residue at position 370, where the antibody optionally comprises one or more further substitutions, deletions and/or insertions, with the proviso that if the antibody has a residue selected from the group consisting of: Lys, Ala, Thr, Met and Leu at the position corresponding to 409, then the antibody does not comprise a Cys-Pro-Pro-Cys sequence in the hinge region.
申请公布号 JP2014122226(A) 申请公布日期 2014.07.03
申请号 JP20140016803 申请日期 2014.01.31
申请人 GENMAB AS 发明人 VAN DE WINKEL JAN;VINK TOM;JANINE SCHUURMAN;PARREN PAUL;ROB AALBERSE;VAN DER NEUT KOLFSCHOTEN MARIJN
分类号 C07K16/46;A61K39/395;A61P1/02;A61P1/04;A61P1/16;A61P1/18;A61P3/00;A61P3/10;A61P7/06;A61P9/00;A61P9/10;A61P11/00;A61P11/06;A61P13/12;A61P15/00;A61P15/10;A61P17/00;A61P17/02;A61P17/06;A61P19/02;A61P19/08;A61P21/00;A61P25/00;A61P25/16;A61P25/28;A61P27/02;A61P29/00;A61P31/04;A61P31/12;A61P31/18;A61P35/00;A61P35/02;A61P35/04;A61P37/02;A61P37/06;A61P37/08;C12N15/09;C12P21/08 主分类号 C07K16/46
代理机构 代理人
主权项
地址